Treatment of STDs in Teenage Males
For a teenage male with suspected STDs, treat empirically with ceftriaxone 250 mg IM plus doxycycline 100 mg orally twice daily for 7 days to cover both gonorrhea and chlamydia, as coinfection is common and compliance with follow-up is often poor in this population. 1
Rationale for Empiric Dual Therapy
Adolescent males frequently have coinfection with both Chlamydia trachomatis and Neisseria gonorrhoeae, making presumptive treatment for both pathogens appropriate when either infection is suspected 1. This approach is particularly critical in teenage populations who demonstrate:
- Erratic health-care seeking behavior
- Poor treatment compliance with multi-day regimens
- Unpredictable follow-up patterns
- High likelihood of not returning for test results 1
Specific Treatment Regimens by Pathogen
Chlamydia Treatment
Primary options:
- Doxycycline 100 mg orally twice daily for 7 days (preferred) 1
- Azithromycin 1 g orally as single dose (alternative for compliance concerns) 1
Doxycycline and azithromycin demonstrate equal efficacy with cure rates of 97-98% 1. However, azithromycin should be prioritized in teenage males specifically because single-dose directly observed therapy maximizes compliance in this population with notoriously poor adherence 1. Despite doxycycline being less expensive, the compliance advantage of azithromycin often makes it more cost-effective in adolescents 1.
Gonorrhea Treatment
Ceftriaxone 250 mg intramuscularly as single dose 2, 3
Note: Older guidelines referenced ceftriaxone 125 mg, but current practice uses 250 mg due to emerging resistance patterns 2.
Syphilis Treatment
For early syphilis (<1 year duration):
- Penicillin G benzathine 2.4 million units IM, single dose 4
For late/unknown duration syphilis:
- Penicillin G benzathine 2.4 million units IM weekly for 3 consecutive weeks 4
Penicillin remains the only acceptable treatment for syphilis across all stages 3, 4.
Genital Herpes Treatment
For first episode:
- Acyclovir, valacyclovir, or famciclovir (specific dosing varies by agent) 5
No cure exists for herpes; treatment focuses on symptom management and reducing transmission 3.
Critical Management Considerations
Medication Dispensing Strategy
Dispense medications on-site and directly observe the first dose 1. This single intervention dramatically improves treatment completion rates in adolescents.
Sexual Abstinence Counseling
Instruct patients to abstain from sexual intercourse for:
- 7 days after single-dose therapy, OR
- Until completion of 7-day regimen 1
Emphasize that abstinence must continue until all sex partners are treated to prevent reinfection 1.
Partner Management
All sex partners from the preceding 60 days must be evaluated and treated presumptively 1, 6. For symptomatic males with urethritis, a 30-day lookback period captures likely transmission sources 6.
Testing Approach
While empiric treatment is often appropriate, when testing is performed:
- Nucleic acid amplification tests (NAATs) are most sensitive for chlamydia and gonorrhea (86-100% sensitivity, 97-100% specificity) 3
- Urine specimens are acceptable for males, avoiding uncomfortable urethral swabs 6
- Consider extragenital testing (rectal, pharyngeal) based on sexual practices 1, 7
Common Pitfalls to Avoid
Don't wait for test results in high-risk adolescents - Treat presumptively if follow-up is uncertain 1
Don't use fluoroquinolones for gonorrhea - Resistance has eliminated these as viable options 1, 3
Don't perform test-of-cure for uncomplicated chlamydia - Unless compliance is questionable or symptoms persist. Testing <3 weeks post-treatment yields false results 1
Don't forget reinfection risk - Adolescents have high reinfection rates; consider retesting at 3 months 1
Don't overlook HIV and syphilis screening - All patients with one STD should be tested for others 8, 3
Special Scenario: Sexual Assault
For adolescent sexual assault victims with vaginal or anal penetration, provide:
- Ceftriaxone 125 mg IM (or cefixime 400 mg orally if only genital penetration)
- Metronidazole 2 g orally once
- Azithromycin 1 g orally once OR doxycycline 100 mg twice daily for 7 days 2
This broader coverage addresses potential trichomonas and bacterial vaginosis exposure.